Question 1

How does Viseven’s AI technology accelerate and improve content creation for life sciences marketing and medical communications?

Accepted Answer

Viseven’s AI-powered content platform, including the AI agent eVa, automates time-consuming tasks in content creation, review, and approval workflows while ensuring compliance with life sciences regulations. It enables the generation of regulatory-friendly draft content, automates metadata tagging, supports modular content reuse, and accelerates Medical, Legal, and Regulatory (MLR) approvals. This streamlines multichannel content management, reduces rework, and helps pharma marketers and medical writers produce accurate, brand-consistent content faster, elevating operational efficiency and engagement in highly regulated environments.

Question 2

What role does Viseven’s AI play in enabling digital transformation for pharmaceutical companies across different stages of maturity?

Accepted Answer

Viseven supports pharma companies at any stage of digital maturity by uniting people, processes, and technology to bridge gaps between strategic goals and operational execution. Their AI-enabled solutions help harmonise content strategy, operations, and multi-channel execution into a seamless ecosystem, facilitating a shift from multichannel to omnichannel marketing. The modular content approach and scalable, API-driven platform enable quick deployment and localisation, helping companies personalise messages effectively while maintaining regulatory compliance globally.

Question 3

How does Viseven ensure AI adoption aligns with industry regulations and maximizes ROI in life sciences marketing?

Accepted Answer

Viseven integrates AI with a strong focus on global regulatory compliance, brand consistency, and localisation requirements specific to the life sciences industry. Their AI models and digital workflows support compliance checks, modular content governance, and regulatory language standards. By automating compliance-heavy tasks and accelerating the MLR process, Viseven reduces bottlenecks common in pharma marketing. This alignment with regulations ensures trustworthy adoption, faster time-to-market, and maximised return on investment through efficient resource utilisation and enhanced customer engagement.

Useful Links

Our Services

Contact Us